Prothena Corp Public Ltd Co financial data

Symbol
PRTA on Nasdaq
Industry
Pharmaceutical Preparations
Location
77 Sir John Rogerson's Quay, Block C, Grand Canal Docklands, Dublin 2, Ireland
State of incorporation
Ireland
Fiscal year end
December 31
Former names
Prothena Corp plc (to 5/22/2020), Neotope Corp Ltd (to 10/1/2012)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.2K % -3.31%
Debt-to-equity 17.5 % -21.4%
Return On Equity -24.2 % -101%
Return On Assets -20.6 % -109%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 53.8M shares +0.27%
Common Stock, Shares, Outstanding 53.8M shares +0.32%
Entity Public Float 2.9B USD +203%
Common Stock, Value, Issued 538K USD +0.37%
Weighted Average Number of Shares Outstanding, Basic 53.8M shares +0.43%
Weighted Average Number of Shares Outstanding, Diluted 53.8M shares -7.27%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 133M USD -5.41%
Research and Development Expense 234M USD +19.8%
General and Administrative Expense 67.3M USD +16%
Operating Income (Loss) -168M USD -49.4%
Nonoperating Income (Expense) 28.1M USD +7.89%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -140M USD -61.9%
Income Tax Expense (Benefit) -8.22M USD +38.3%
Net Income (Loss) Attributable to Parent -132M USD -80.1%
Earnings Per Share, Basic -2.45 USD/shares -81.5%
Earnings Per Share, Diluted -2.44 USD/shares -76.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 519M USD -22.6%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 535M USD -22.5%
Deferred Income Tax Assets, Net 41M USD +37.1%
Property, Plant and Equipment, Net 3.25M USD +33.7%
Operating Lease, Right-of-Use Asset 11.4M USD -9.73%
Other Assets, Noncurrent 3.75M USD -64.2%
Assets 595M USD -20.3%
Accounts Payable, Current 10.3M USD -46.9%
Employee-related Liabilities, Current 11.9M USD +11.2%
Liabilities, Current 46.4M USD -13%
Operating Lease, Liability, Noncurrent 8.88M USD -0.42%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 60.9M USD -53%
Retained Earnings (Accumulated Deficit) -1.04B USD -14.4%
Stockholders' Equity Attributable to Parent 534M USD -13.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 534M USD -13.4%
Liabilities and Equity 595M USD -20.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -73.1M USD -53.9%
Net Cash Provided by (Used in) Financing Activities 836K USD -96.4%
Net Cash Provided by (Used in) Investing Activities -103K USD -115%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 53.8M shares +0.32%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 520M USD -22.7%
Deferred Tax Assets, Valuation Allowance 182M USD +12.8%
Deferred Tax Assets, Gross 219M USD +21%
Operating Lease, Liability 11.5M USD +7.07%
Depreciation 900K USD +28.6%
Lessee, Operating Lease, Liability, to be Paid 12.9M USD -21.7%
Property, Plant and Equipment, Gross 11.3M USD -20.4%
Operating Lease, Liability, Current 2.61M USD +43.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.16M USD +3.47%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.19M USD +12.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.45M USD -75%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.27M USD +3.52%
Deferred Tax Assets, Operating Loss Carryforwards 156M USD +14.3%
Unrecognized Tax Benefits 13.4M USD +15.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.52M USD -22.8%
Operating Lease, Payments 0 USD -100%
Additional Paid in Capital 1.58B USD +3.2%
Depreciation, Depletion and Amortization 215K USD +6.97%
Deferred Tax Assets, Net of Valuation Allowance 37.1M USD +87.8%